HealthLynked Corp. Issues $5.7M Secured Convertible Note to CEO's Trust, Consolidating Debt

summarizeSummary

HealthLynked Corp. issued a $5.7 million senior secured convertible promissory note to a trust controlled by its CEO, Dr. Michael Dent, consolidating existing debt and unpaid compensation and securing it with a first-priority lien on all company assets.

check_boxKey Events

• New Secured Convertible Note Issued

  HealthLynked Corp. issued a Senior Secured Convertible Promissory Note with a principal amount of $5,715,811.98.

• Insider Lender and Asset Security

  The note was issued to the Mary S. Dent Gifting Trust, controlled by CEO and Chairman Dr. Michael Dent, and is secured by a first-priority lien on all of the company's assets.

• Consolidation of Existing Obligations

  The note consolidates prior obligations, including existing promissory notes, undocumented advances, and unpaid compensation to Dr. Dent, totaling the principal amount.

• Conversion Terms and High Interest Rate

  The note carries a 12% annual interest rate (18% upon default) and is convertible into common stock at $4.25 per share, which is above the current market price.

auto_awesomeAnalysis

This filing reveals a critical restructuring of HealthLynked Corp.'s financial obligations, formalizing a substantial $5.7 million debt to a trust controlled by its CEO, Dr. Michael Dent. The note, which represents a significant portion of the company's current valuation, is secured by a first-priority lien on all company assets, significantly increasing risk for other creditors and shareholders. While it consolidates prior obligations, including undocumented advances and long-standing unpaid compensation, and features a conversion price above the current stock price, the high 12% interest rate and the extensive security granted to an insider highlight the company's precarious financial position and the significant concessions made to secure this financing. The Most Favored Nation clause further protects the insider's investment. This transaction raises concerns about corporate governance and the company's ability to secure external, non-insider financing on more favorable terms.